UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020396
Receipt number R000023548
Scientific Title Effectiveness of Vasopressin During laparoscopic Hysterectomy
Date of disclosure of the study information 2016/01/01
Last modified on 2023/07/09 18:37:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of Vasopressin During laparoscopic Hysterectomy

Acronym

Vasopressin During laparoscopic Hysterectomy

Scientific Title

Effectiveness of Vasopressin During laparoscopic Hysterectomy

Scientific Title:Acronym

Vasopressin During laparoscopic Hysterectomy

Region

Japan


Condition

Condition

Myoma uteri, adenomyosis

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is the evaluation for safety
and efficiency of use of vasopressin during laparoscopic hysterectomy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Operation time, Blood loss.

Key secondary outcomes

Complications, duration of hospitalization.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Injection of dilute vasopressin solution to uterine myometrium

Interventions/Control_2

injection of physiological saline solution to uterine myometrium

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Female

Key inclusion criteria

Women who have symptomatic uterine
myomas and/or adenomyosis

Key exclusion criteria

1. Patients with severe complications.
2. Laparoscopic hysterectomy for cervical myoma with a major diameter of more than 10 cm.
3. Patients who are judged to be inappropriate to carry out the study by the medical attendant.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Fumiaki
Middle name
Last name Taniguchi

Organization

Takanohara Central Hospital

Division name

Department of Obstetrics and Gynecology

Zip code

631-0805

Address

1-3-3 Ukyo, Nara city, Nara, 631-0805, Japan

TEL

0742-71-1030

Email

ftaniguc@gmail.com


Public contact

Name of contact person

1st name Fumiaki
Middle name
Last name Taniguchi

Organization

Takanohara Central Hospital

Division name

Department of Obstetrics and Gynecology

Zip code

631-0805

Address

1-3-3 Ukyo, Nara city, Nara, 631-0805, Japan

TEL

0742-71-1030

Homepage URL


Email

ftaniguc@gmail.com


Sponsor or person

Institute

Takanohara Central Hospital

Institute

Department

Personal name



Funding Source

Organization

Takanohara Central Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Takanohara Central Hospital Ethics Committee

Address

1-3-3 Ukyo, Nara city, Nara, Japan

Tel

0742-71-1030

Email

info@takanohara-ch.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 10 Month 01 Day

Date of IRB

2015 Year 11 Month 09 Day

Anticipated trial start date

2015 Year 10 Month 01 Day

Last follow-up date

2022 Year 09 Month 30 Day

Date of closure to data entry

2022 Year 12 Month 31 Day

Date trial data considered complete

2022 Year 12 Month 31 Day

Date analysis concluded

2023 Year 10 Month 30 Day


Other

Other related information



Management information

Registered date

2015 Year 12 Month 29 Day

Last modified on

2023 Year 07 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023548


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name